2010
DOI: 10.1007/s11426-010-0021-3
|View full text |Cite
|
Sign up to set email alerts
|

Carbohydrate biomarkers for future disease detection and treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
12
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 31 publications
(12 citation statements)
references
References 320 publications
(327 reference statements)
0
12
0
Order By: Relevance
“…The mice inoculated with Gram-negative bacteria, and its LPS showed great elevation in haptoglobin and other acute-phase proteins. The suspicious role of sharp induction for acute-phase proteins in inflammation, neuronal necrosis, and cerebral vascular congestion has been deeply in murine [ 72 ].…”
Section: Acute-phase Proteinsmentioning
confidence: 99%
“…The mice inoculated with Gram-negative bacteria, and its LPS showed great elevation in haptoglobin and other acute-phase proteins. The suspicious role of sharp induction for acute-phase proteins in inflammation, neuronal necrosis, and cerebral vascular congestion has been deeply in murine [ 72 ].…”
Section: Acute-phase Proteinsmentioning
confidence: 99%
“…BPN capsules are stable in the presence of the competing carbohydrates in biological environments, which gives BPN capsules the potential to be exploited in biological applications. For example, intracellular drug delivery systems, extracellular remote‐controlled drug delivery systems, closed‐loop insulin delivery systems, biological targeting systems, and biomimetic protocells could all potentially be engineered from BPN capsules.…”
mentioning
confidence: 99%
“…To ensure the feasibility of the complete automation, a new type of linker (13) stable under the most common glycosylation and protecting group removal conditions was introduced. The synthesis of pentasaccharide (18) began with the assembly of the chitobiose portion using two glycosylation-deprotection cycles with the glycosyl donor (14). A challenging β-mannosidic linkage was then obtained with a donor (15), equipped with a 2-(hydroxycarbonyl)benzyl leaving group developed by Kim [112].…”
Section: Dedicated Oligosaccharide Synthesizer For the Automation Of mentioning
confidence: 99%
“…Isolation from natural sources offers another viable means to obtain sugars. Only the synthetic approach, however, can provide unnatural glycomimetics, which are often of interest due to their therapeutic [4,14] and/or diagnostic potential [15][16][17]. Manufacturers have shown an interest in producing carbohydrate-based pharmaceuticals; however, even with significant progress, controlled chemical synthesis of complex carbohydrates remains difficult.…”
mentioning
confidence: 99%